Showing results (2431-2440 of 9,335) with videos related to

Sort By:
Pageof 934
Cancer Medicine|September 14, 2019
Endocrine-related adverse events associated with immune-checkpoint inhibitors in patients with melanomaEva Kassi, Anna Angelousi, Nikolaos Asonitis, et al.
Cancer Medicine|September 17, 2019
Mitomycin and 5-fluorouracil for second-line treatment of metastatic squamous cell carcinomas of the anal canalAngélique Saint, Ludovic Evesque, Alexander T Falk, et al.
Cancer Medicine|September 19, 2019
The clinical behavior and survival of patients with hepatocellular carcinoma and a family history of the diseaseJihyun An, Seheon Chang, Ha Il Kim, et al.
Cancer Medicine|August 19, 2019
All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: A review and modeling studyEveline A M Heijnsdijk, Marcell Csanádi, Andrea Gini, et al.
Cancer Medicine|August 21, 2019
PD-L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagusMatteo Fassan, Francesco Cavallin, Vincenza Guzzardo, et al.
Cancer Medicine|August 21, 2019
Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver diseaseCortlandt M Sellers, Johannes Uhlig, Johannes M Ludwig, et al.
Cancer Medicine|August 23, 2019
Long noncoding RNA PART1 promotes progression of non-small cell lung cancer cells via JAK-STAT signaling pathwayDengyan Zhu, Yang Yu, Wei Wang, et al.
Cancer Medicine|August 23, 2019
The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insuranceCortlandt M Sellers, Johannes Uhlig, Johannes M Ludwig, et al.
Cancer Medicine|September 6, 2019
ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single-center clinical utility study-PRECISE studyLennard Y W Lee, Thomas Starkey, Shivan Sivakumar, et al.
Cancer Medicine|September 7, 2019
Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic reviewYining Gong, Lingyi Xu, Hongqing Zhuang, et al.
Pageof 934